Membership Home Portfolio Stocks Bonds Funds ETFs CEFs Markets Tools Real Life Finance Discuss

Articles From: Zep Inc. Completes Third Phase of SAP Enterprise Control Center 6.0 ERP Solution to rue21, inc. Announces Fourth Quarter and Full Year Fiscal 2012 Earnings Conference Call

This site contains about 63,386 documents.
View by:
Title  |  Date  |  Author  |  Collection  |  Interest  |  Popularity
Page:   1   100   210   220   230   240   250   260   270   280   290   300   301   302   303   304   305   306   307   308   309   310   311   312   313   314   315   316   317   318   319   320   321   322   323   324   325   326   327   328   329   330   340   350   360   370   380   390   400   410   500   600   700   800   900   1,000   1,100   1,200   1,300   2,000   2,113 

2013/3/7
Zep Inc. Completes Third Phase of SAP Enterprise Control Center 6.0 ERP Solution
Zep Inc. (NYSE:ZEP) , a leading consumable packaged goods company, today announced that it has completed the third phase of its Enterprise Control Center (“ECC”) 6.0 ERP Solution from SAP.
View more Zep Inc. Completes Third Phase of SAP Enterprise Control Center 6.0 ERP Solution analysis
Sign-up for Zep Inc. Completes Third Phase of SAP Enterprise Control Center 6.0 ERP Solution investment picks
2013/3/7
ZAGG Inc to Present at 25th Annual ROTH Conference
ZAGG Inc (NASDAQ: ZAGG) , a leading mobile device accessories company, today announced that the company will be presenting at the 25th Annual ROTH Conference, being held at the Ritz-Carlton in Laguna Niguel, CA, on Monday, March 18, 2013 at 8:00 a.m. Pacific time (11:00 a.m. Eastern time). Randy Hales, president and chief executive officer, and Brandon O'Brien, chief financial officer, will host the presentation.
View more ZAGG Inc to Present at 25th Annual ROTH Conference analysis
Sign-up for ZAGG Inc to Present at 25th Annual ROTH Conference investment picks
2013/3/7
Blount Announces Fourth Quarter 2012 Results and Provides Full Year 2013 Guidance
- Fourth quarter 2012 sales of $230 million - Fourth quarter 2012 FLAG sales increased two percent, excluding currency impacts, compared to fourth quarter 2011 - 2013 full year sales growth of zero to five percent expected PORTLAND, Ore.
View more Blount Announces Fourth Quarter 2012 Results and Provides Full Year 2013 Guidance analysis
Sign-up for Blount Announces Fourth Quarter 2012 Results and Provides Full Year 2013 Guidance investment picks
2013/3/7
UnitedHealth Group Drs. Deneen Vojta and Richard Smith to Address the 25th Anniversary Nobel Peace Prize Forum
Deneen Vojta, M.D., and Richard Smith, M.D., two of UnitedHealth Group’s leading chronic disease experts, will address the 25 th Anniversary Nobel Peace Prize Forum , March 8-10 at Augsburg College in Minneapolis.
View more UnitedHealth Group Drs. Deneen Vojta and Richard Smith to Address the 25th Anniversary Nobel Peace Prize Forum analysis
Sign-up for UnitedHealth Group Drs. Deneen Vojta and Richard Smith to Address the 25th Anniversary Nobel Peace Prize Forum investment picks
2013/3/7
Winthrop Realty Trust Announces Results for Fourth Quarter and Full Year 2012
Declares First Quarter 2013 Cash Dividend Reports Fourth Quarter Investments of $144.5 Million BOSTON, March 7, 2013 (GLOBE NEWSWIRE) -- Winthrop Realty Trust (NYSE:FUR) , a leading real estate value investor, announced today financial and operating results for the fourth quarter and full year ended December 31, 2012.
View more Winthrop Realty Trust Announces Results for Fourth Quarter and Full Year 2012 analysis
Sign-up for Winthrop Realty Trust Announces Results for Fourth Quarter and Full Year 2012 investment picks
2013/3/7
Cabot Corporation Debuts New Brand Identity
Cabot Corp.
View more Cabot Corporation Debuts New Brand Identity analysis
Sign-up for Cabot Corporation Debuts New Brand Identity investment picks
2013/3/7
Barcelona City Hall Launches a Pioneer Virtual Citizen Services Centre in Europe
http://media.marketwire.com/attachments/201210/90690_Cisco_logo.gif http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=993784&ProfileId=051205&sourceType=1 BARCELONA, SPAIN --
View more Barcelona City Hall Launches a Pioneer Virtual Citizen Services Centre in Europe analysis
Sign-up for Barcelona City Hall Launches a Pioneer Virtual Citizen Services Centre in Europe investment picks
2013/3/7
Internet of Things World Forum Event Aims to Accelerate Innovation, Inspire New Ways to Transform Governments, Industries and Lives
http://media.marketwire.com/attachments/201210/90690_Cisco_logo.gif http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=994136&ProfileId=051205&sourceType=1 SAN JOSE, CA --
View more Internet of Things World Forum Event Aims to Accelerate Innovation, Inspire New Ways to Transform Governments, Industries and Lives analysis
Sign-up for Internet of Things World Forum Event Aims to Accelerate Innovation, Inspire New Ways to Transform Governments, Industries and Lives investment picks
2013/3/7
Fluor Recognized on Ethisphere’s World Most Ethical Companies List for Seventh Straight Year
Fluor Corporation (NYSE: FLR) announced today that it was named as one of the Ethisphere Institute’s World’s Most Ethical (WME) Companies for 2013.
View more Fluor Recognized on Ethisphere’s World Most Ethical Companies List for Seventh Straight Year analysis
Sign-up for Fluor Recognized on Ethisphere’s World Most Ethical Companies List for Seventh Straight Year investment picks
2013/3/7
Liquidmetal Technologies to Present at the 25th Annual ROTH Conference on March 20, 2013
Liquidmetal® Technologies, Inc. (LTI) (OTCQB: LQMT), the leading developer of amorphous alloys and composites, has been invited to present at the ROTH Capital Partners 25th Annual Conference being held on March 17-20, 2013 at The Ritz-Carlton, Laguna Niguel in Dana Point, California.
View more Liquidmetal Technologies to Present at the 25th Annual ROTH Conference on March 20, 2013 analysis
Sign-up for Liquidmetal Technologies to Present at the 25th Annual ROTH Conference on March 20, 2013 investment picks
2013/3/7
Aflac's New Calculator Helps Show Real Cost of Accident and Illness
Innovative online tool helps educate consumers by illustrating medical, household and out-of-pocket expenses for treatment of specific injuries and diseases COLUMBUS, Ga.
View more Aflac's New Calculator Helps Show Real Cost of Accident and Illness analysis
Sign-up for Aflac's New Calculator Helps Show Real Cost of Accident and Illness investment picks
2013/3/7
PHD Virtual Raises $4 Million
PHD Virtual Technologies, a pioneer in virtual machine backup and recovery , and innovator of virtualization monitoring solutions , announced today that it has raised $4 million recently with $2 Million in Series C funding led by Insight Venture Partners and Citrix (NASDAQ: CTXS) , both current investors in the company, and a $2 million venture debt financing from Wellington Financial.
View more PHD Virtual Raises $4 Million analysis
Sign-up for PHD Virtual Raises $4 Million investment picks
2013/3/7
Three GE Engineers Elected to National Academy of Engineering
GE (NYSE: GE) today announced that three distinguished engineers, one from the company’s Global Research Center, and two from its Aviation business, have been elected to the National Academy of Engineering.
View more Three GE Engineers Elected to National Academy of Engineering analysis
Sign-up for Three GE Engineers Elected to National Academy of Engineering investment picks
2013/3/7
Amarin Announces Notification of Patent Allowance for U.S. Application 13/614,111 Related to Vascepa(R) and Planned ANCHOR Indication
BEDMINSTER, N.J., and DUBLIN, Ireland, March 7, 2013 (GLOBE NEWSWIRE) -- Amarin Corporation plc (Nasdaq:AMRN) , a biopharmaceutical company focused on the commercialization and development of therapeutics to improve cardiovascular health, announced today that the United States Patent and Trademark Office (USPTO) has published notification of a Notice of Allowance for Amarin's U.S. Patent Application Serial Number 13/614,111titled "Stable Pharmaceutical Compositions and Methods of Using the Same." This application includes claims intended to protect the proposed Vascepa ® (icosapent ethyl) indication based on Amarin's Phase 3 ANCHOR clinical trial results.
View more Amarin Announces Notification of Patent Allowance for U.S. Application 13/614,111 Related to Vascepa(R) and Planned ANCHOR Indication analysis
Sign-up for Amarin Announces Notification of Patent Allowance for U.S. Application 13/614,111 Related to Vascepa(R) and Planned ANCHOR Indication investment picks
2013/3/7
EDAC Technologies Reports Strong Results for Fiscal 2012 Fourth Quarter
- Sales Reach Record $28.4 Million, including $2.9 Million of EBTEC Sales - Net Income Rises 31% to $1.5 Million, or $0.26 per Diluted Share - Full Year Sales of $106.5 Million and EPS of $1.04 also at Record Levels - Backlog at Quarter-End Totals $304 Million FARMINGTON, Conn.
View more EDAC Technologies Reports Strong Results for Fiscal 2012 Fourth Quarter analysis
Sign-up for EDAC Technologies Reports Strong Results for Fiscal 2012 Fourth Quarter investment picks
2013/3/7
Fred's Reports February Sales
Fred's Inc. (NASDAQ: FRED) today reported sales for the four-week month of February, the first month of fiscal 2013, which ended March 2, 2013.
View more Fred's Reports February Sales analysis
Sign-up for Fred's Reports February Sales investment picks
2013/3/7
Sonic Foundry Announces Mediasite Enterprise Video Platform
Sonic Foundry, Inc. (NASDAQ: SOFO) , the trusted market leader for video management and academic, enterprise and event webcasting , today announced a major milestone with the introduction of Mediasite Enterprise Video Platform.
View more Sonic Foundry Announces Mediasite Enterprise Video Platform analysis
Sign-up for Sonic Foundry Announces Mediasite Enterprise Video Platform investment picks
2013/3/7
Willbros Announces Fourth Quarter and Full Year 2012 Earnings Release and Conference Call Schedule
HOUSTON , March 4, 2013 /PRNewswire/ -- Willbros Group, Inc. (NYSE: WG) announces plans to release its fourth quarter 2012 results on Wednesday, March 6, 2013 after the market closes.
View more Willbros Announces Fourth Quarter and Full Year 2012 Earnings Release and Conference Call Schedule analysis
Sign-up for Willbros Announces Fourth Quarter and Full Year 2012 Earnings Release and Conference Call Schedule investment picks
2013/3/7
Tandy Leather Factory Reports February 2013 Sales Up 8% Over February 2012
FORT WORTH, Texas, March 7, 2013 (GLOBE NEWSWIRE) -- Tandy Leather Factory, Inc. (Nasdaq:TLF) reported today that sales for the month of February were $6.3 million, up 8% compared to February 2012 sales of $5.8 million.
View more Tandy Leather Factory Reports February 2013 Sales Up 8% Over February 2012 analysis
Sign-up for Tandy Leather Factory Reports February 2013 Sales Up 8% Over February 2012 investment picks
2013/3/7
PULSE: Limited Brands same-store sales rise 3%
NEW YORK (MarketWatch) -- Limited Brands Inc. LTD reported on Thursday a 3% increase in same-store sales for the four weeks ended March 2 compared with a year ago.
View more PULSE: Limited Brands same-store sales rise 3% analysis
Sign-up for PULSE: Limited Brands same-store sales rise 3% investment picks
2013/3/7
Amicus Therapeutics to Announce Full-Year 2012 Financial Results on March 12, 2013
CRANBURY, N.J., March 7, 2013 (GLOBE NEWSWIRE) -- Amicus Therapeutics (Nasdaq:FOLD) today announced a conference call and live audio webcast on Tuesday, March 12, 2013 at 5:00 p.m. ET to discuss financial results for the full-year ended December 31, 2012.
View more Amicus Therapeutics to Announce Full-Year 2012 Financial Results on March 12, 2013 analysis
Sign-up for Amicus Therapeutics to Announce Full-Year 2012 Financial Results on March 12, 2013 investment picks
2013/3/7
POZEN to Present at the 25th Annual ROTH Conference
POZEN Inc. (NASDAQ: POZN) , a pharmaceutical company committed to transforming medicine that transforms lives, announced today that John R.
View more POZEN to Present at the 25th Annual ROTH Conference analysis
Sign-up for POZEN to Present at the 25th Annual ROTH Conference investment picks
2013/3/7
AcelRx Pharmaceuticals to Hold Fourth Quarter 2012 Financial Results Conference Call and Webcast on March 12, 2013
REDWOOD CITY, Calif.
View more AcelRx Pharmaceuticals to Hold Fourth Quarter 2012 Financial Results Conference Call and Webcast on March 12, 2013 analysis
Sign-up for AcelRx Pharmaceuticals to Hold Fourth Quarter 2012 Financial Results Conference Call and Webcast on March 12, 2013 investment picks
2013/3/7
Bankrate: Mortgage Rates Hold Steady Ahead of Jobs Report
NEW YORK , March 7, 2013 /PRNewswire/ -- Fixed mortgage rates were mostly unchanged, with the benchmark 30-year fixed mortgage rate holding at 3.73 percent this week, according to Bankrate.com's weekly national survey.
View more Bankrate: Mortgage Rates Hold Steady Ahead of Jobs Report analysis
Sign-up for Bankrate: Mortgage Rates Hold Steady Ahead of Jobs Report investment picks
2013/3/7
Uroplasty To Present At The 25th Annual ROTH Growth Stock Conference
MINNEAPOLIS , March 7, 2013 /PRNewswire/ -- Uroplasty, Inc. (NASDAQ: UPI) , a medical device company that develops, manufactures and markets innovative proprietary products to treat voiding dysfunctions, announced today that David Kaysen , President and CEO, and Darin Hammers , Vice President of US Sales, will present the Company's business strategy and financial results at the 25th Annual ROTH Growth Stock Conference at 8:30 AM PT on Monday, March 18, 2013 at The Ritz Carlton in Dana Point, CA.
View more Uroplasty To Present At The 25th Annual ROTH Growth Stock Conference analysis
Sign-up for Uroplasty To Present At The 25th Annual ROTH Growth Stock Conference investment picks
2013/3/7
Repligen Reports Fourth Quarter and Full Year 2012 Financial Results and Provides Financial Guidance for 2013
- Bioprocessing Revenue Increases to $42 Million, Total Revenue Reaches $63 Million in 2012 - - Year-over-Year Net Income Increases by $18 Million - WALTHAM, Mass., March 7, 2013 (GLOBE NEWSWIRE) -- Repligen Corporation (Nasdaq:RGEN) today reported financial results for its fourth quarter and year ended December 31, 2012.
View more Repligen Reports Fourth Quarter and Full Year 2012 Financial Results and Provides Financial Guidance for 2013 analysis
Sign-up for Repligen Reports Fourth Quarter and Full Year 2012 Financial Results and Provides Financial Guidance for 2013 investment picks
2013/3/7
Merck Announces Appointment of Roger M. Perlmutter, M.D., Ph.D., As President of Merck Research Laboratories; Peter S. Kim, Ph.D., to Retire
Merck (NYSE: MRK) , known as MSD outside the United States and Canada, today announced the appointment of Roger M.
View more Merck Announces Appointment of Roger M. Perlmutter, M.D., Ph.D., As President of Merck Research Laboratories; Peter S. Kim, Ph.D., to Retire analysis
Sign-up for Merck Announces Appointment of Roger M. Perlmutter, M.D., Ph.D., As President of Merck Research Laboratories; Peter S. Kim, Ph.D., to Retire investment picks
2013/3/7
Cadence Pharmaceuticals Reports Fourth Quarter and Full Year 2012 Financial Results
-- 2012 Net Product Revenue Exceeds $50 Million --
View more Cadence Pharmaceuticals Reports Fourth Quarter and Full Year 2012 Financial Results analysis
Sign-up for Cadence Pharmaceuticals Reports Fourth Quarter and Full Year 2012 Financial Results investment picks
2013/3/7
Coronado Biosciences to Report Fourth Quarter and Full Year 2012 Results
BURLINGTON, Mass., March 7, 2013 (GLOBE NEWSWIRE) -- Coronado Biosciences, Inc. (Nasdaq:CNDO) , a biopharmaceutical company focused on the development of novel immunotherapy biologic agents for the treatment of autoimmune diseases and cancer, announced today that it will report its financial results for the fourth quarter and full year 2012, on Thursday, March 14, 2013 at 8:30 AM ET.
View more Coronado Biosciences to Report Fourth Quarter and Full Year 2012 Results analysis
Sign-up for Coronado Biosciences to Report Fourth Quarter and Full Year 2012 Results investment picks
2013/3/7
rue21, inc. Announces Fourth Quarter and Full Year Fiscal 2012 Earnings Conference Call
WARRENDALE, Pa., March 7, 2013 (GLOBE NEWSWIRE) -- rue21, inc.
View more rue21, inc. Announces Fourth Quarter and Full Year Fiscal 2012 Earnings Conference Call analysis
Sign-up for rue21, inc. Announces Fourth Quarter and Full Year Fiscal 2012 Earnings Conference Call investment picks
Start Premium Trial Register For Free

P F Fund Financial Data (13,000+ funds)
P F Stock Financial Data (7,000+ stocks)
P F Stock and Fund Screeners (basic)
P F Investing Articles and Market Commentary
P F Articles Archive (>30 days)
P F Discuss (dozens of stock, fund, bond, and general bulletin boards)
P F Portfolio Manager (basic)
P F Morningstar Investment Classroom
P F Morningstar Investing Classroom Rewards (earn as you learn and redeem for Morningstar merchandise)
P   Morningstar Fund Analyst Reports (full research on 2,000 funds and ETFs)
P   Morningstar Stock Analyst Reports (full research on 2,000 stocks)
P   Morningstar Stock and Fund Stewardship Grades
P   Portfolio Manager (advanced with 10 x-ray analyses, including guidance)
P   Portfolio Monitor (monthly and on-demand personalized portfolio statements)
P   Morningstar Proprietary Stock Information (stock star ratings, buy/sell prices, economic moat ratings, and more)
P   Morningstar Stock and Fund Favorites & Red Flags eNewsletters
P   Premium Stock and Fund Screeners (advanced with nearly infinite ways to find the best securities for you)
P   Discounts on Morningstar newsletters, books, seminars, and more

Sign-up to Morningstar


Basic Access

Articles and Videos
Morningstar video reports, articles, data, and tools. Dig into our lineup of e-newsletters and investing classroom courses outlining sensible strategies for maximizing your investments.
Morningstar Discuss
Follow the buzz on individual stocks or fund families. Plus, read the latest posts from Morningstar members and analysts.
Portfolio Manager
Track your investments and watch lists with our Portfolio Manager. Customize your view with our comprehensive stock, fund, and ETF data.

Access these features and more when you sign up for Free Membership.
Join Morningstar today. It's Free.

Unlimited Access

Analyst Research
Gather in-depth, actionable insight on over 3,700 stock and mutual funds covered by Morningstar analysts. View our mutual fund Analyst Reports favored by professionals, savvy experienced investors, and new investors researching options for retirement savings, college plans, or other investment needs.
Portfolio X-Ray®
Ensure your portfolio is positioned exactly how you want with Morningstar's X-Ray Interpreter and Stock Intersection tools. A Barron's "Best of the Web" award winner for five years running, X-Ray Interpreter goes under the hood of your portfolio to provide a useful allocation, sector, and geographic analysis. And you can discover how much of a stock you really own, individually and through mutual funds, with Stock Intersection.
Investment Picks
Find new 5-star stocks (greatly undervalued companies) to consider daily. Our 5-star stock rating is a proven winner, consistently beating benchmarks like the S&P 500. Plus, browse our Fund Analyst Picks and Stewardship Grades to find shareholder-friendly mutual funds that are poised for outperformance.
Portfolio Monitor
Get a clear view of your investments with personalized reports about your portfolio. Receive monthly statements and generate reports on-demand to help you stay on track to meet your investment goals.

Access these features and more when you sign up for Premium Membership.
Start your free 14-day trial today online
Your subscription may be tax deductible. Please contact your tax advisor.

Site Directory Site Map Our Products
Corrections Help Advertising Opportunities Licensing Opportunities Glossary RSS Mobile Portfolio Affiliate Careers Company News
Articles From: Zep Inc. Completes Third Phase of SAP Enterprise Control Center 6.0 ERP Solution to rue21, inc. Announces Fourth Quarter and Full Year Fiscal 2012 Earnings Conference Call
Stocks by:
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry
Mutual Funds by:
Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title
ETFs by:
Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name
Investment Categories by:
Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry
Premimum Stocks by:
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry
Premimum Funds by:
Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title
Premimum ETFs by:
Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name
Popular Articles by:
Title |  Date |  Author |  Collection |  Popularity |  Interest
SEC Filings by:
Title |  Date |  Company |  Symbol |  Interest |  Popularity
Popular SEC Filings by:
Title |  Date |  Company |  Symbol |  Interest |  Popularity
Independent. Insightful. Trusted. Morningstar provides stock market analysis; equity, mutual fund, and ETF research, ratings, and picks; portfolio tools; and option, hedge fund, IRA, 401k, and 529 plan research. Our reliable data and analysis can help both experienced enthusiasts and newcomers.

© Copyright 2013 Morningstar, Inc. All rights reserved. Please read our Terms of Useand Privacy Policy.Dow Jones Industrial Average, S&P 500, Nasdaq, and Morningstar Index (Market Barometer) quotes are real-time.